Mayevskaya, M. V., Ivashkin, V. T., Znoyko, O. O., Klimova, Y. A., Abdurakhmanov, D. T., Bakulin, I. G., . . . Samsonov, M. Y. Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study). Gastro LLC.
Chicago Style (17th ed.) CitationMayevskaya, M. V., et al. Efficacy and Safety of the Russian Protease Inhibitor Narlaprevir at Treatment-naive and Earlier Treated Noncirrhotic Patients with the 1st Genotype Chronic Hepatitis C (PIONEER Study). Gastro LLC.
MLA (9th ed.) CitationMayevskaya, M. V., et al. Efficacy and Safety of the Russian Protease Inhibitor Narlaprevir at Treatment-naive and Earlier Treated Noncirrhotic Patients with the 1st Genotype Chronic Hepatitis C (PIONEER Study). Gastro LLC.